KOSDAQ · Healthcare · ₩2T
₩109,300+9.52%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 10.5% · as of 26.09.11
Among 36 신약 개발 peers
Quarterly Revenue Growth
“기술이전 성과가 다음 실적의 방향을 정하는 분기예요.”
In the company's words · 2026 2분기 filing